Related Experiment Video
Updated: Oct 28, 2026

Structured Exercise Regimen in Pulmonary Hypertension-Right Ventricular Failure in an Ovine Model
Published on: May 5, 2026
Blueberry Extract and Resistance Training in Severe Pulmonary Arterial Hypertension: Effects on Lung and
Luciano Bernardes Leite1, Leôncio Lopes Soares2, Sebastião Felipe Ferreira Costa1
1Exercise Biology Laboratory, Department of Physical Education, Federal University of Viçosa, Viçosa 36570-900, MG, Brazil.
Abstract:
This study evaluated the effects of blueberry extract and resistance training on lung and right ventricle (RV) function and structure in severe experimental pulmonary arterial hypertension (PAH). PAH was induced in male Wistar rats by a single intraperitoneal injection of monocrotaline (60 mg/kg). One day later, the animals started receiving blueberry extract (100 mg/kg daily by gavage) and underwent a three-week moderate-intensity resistance exercise protocol (ladder climbing-15 climbs, a 60 s interval, a 60% load, one session/day, 5 days/wk). After these treatments and echocardiographic assessment, the animals were euthanized, and lung and RV samples were collected for mechanical, morphological, biochemical, and molecular analyses. Both blueberry extract and resistance training attenuated RV dysfunction and pulmonary artery resistance observed over the development of severe PAH. In addition, single RV myocyte mechanical function was maintained in treated rats. Moreover, the applied treatments mitigated oxidative imbalance and adverse structural remodeling in both the lung and RV. Furthermore, the interventions promoted partial or complete preservation of calcium regulatory protein expression. In conclusion, blueberry extract and resistance training, either alone or in combination, alleviate cardiopulmonary oxidative imbalance and adverse structural remodeling, sustain RV myocyte contractility and the expression of calcium regulatory proteins, and thus conserve pulmonary and RV function in severe PAH induced by monocrotaline.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Heart Failure Drugs: β-Blockers
